Feuerstein Instrumental Enrichment Program for People With Schizophrenia After the First Episode of Psychosis: Protocol for an Open-Label Intervention Study

被引:0
|
作者
Fonseca, Ana Olivia [1 ,2 ]
Gomes, July Silveira [1 ,2 ]
Novaes, Rafael Angulo Condoretti Barros [3 ]
Dias, Cintia Lopes [1 ,2 ]
Rodrigues, Maria Eva de Miranda Alves [1 ]
Gadelha, Ary [1 ,2 ]
Noto, Cristiano [1 ,2 ]
机构
[1] Univ Fed Sao Paulo, Psychiat Dept, Episode Program 1, 241 Rua Major Maragliano,Vila Mariana, BR-04017030 Sao Paulo, Brazil
[2] Univ Fed Sao Paulo, Clin Neurosci Lab, Sao Paulo, Brazil
[3] Univ Fed Sao Paulo, Psychobiol Dept, Sao Paulo, Brazil
来源
JMIR RESEARCH PROTOCOLS | 2024年 / 13卷
关键词
schizophrenia; Feuerstein Instrumental Enrichment program; cognitive intervention; functionality; first-episode psychosis; early stages; Feuerstein Instrumental Enrichment; FIE; psychotic disorder; psychotic disorders; neurocognitive deficits; economicburden; cognitive rehabilitation; quality of life; daily living; cognitive assessment; maze task; mental disorder; cognitive deficits; mental health; psychosis; COGNITIVE REMEDIATION; REHABILITATION; METAANALYSIS; 1ST-EPISODE; SYMPTOMS; WORLD;
D O I
10.2196/57031
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Schizophrenia is a disorder associated with neurocognitive deficits that adversely affect daily functioning and impose an economic burden. Cognitive rehabilitation interventions, particularly during the early phases of illness, have been shown to improve cognition, functionality, and quality of life. The Feuerstein Instrumental Enrichment (FIE) program, based on the Mediated Learning Experience and the Structural Cognitive Modifiability theory, has been applied in various disorders, but its applicability in schizophrenia has not yet been clarified. Objective: This study aims to investigate the effects of the FIE program on the functionality of patients with first-episodeschizophrenia. Methods: In total, 17 patients will be recruited for an open-label intervention consisting of twice-weekly sessions for 10 weeks. The primary outcome measure will be changes in the Goal Achievement Scale score. Maze task performance from the Measurementand Treatment Research to Improve Cognition in Schizophrenia (MATRICS) battery will serve as a secondary outcome measure.At the same time, changes in Positive and Negative Syndrome Scale scores and other MATRICS domains will be analyzed asexploratory outcomes. Assessments will be administered before and after the intervention, with a follow-up period of 6 months. Results: This trial was preregistered in The Brazilian Registry of Clinical Trials (RBR-4gzhy4s). By February 2024, 11participants were enrolled in the training. Recruitment is expected to be completed by May 2024. Data analysis will be conductedbetween May and September 2024. The results are expected to be published in January 2025. Conclusions: This study may establish a protocol for the FIE program that uses mediation techniques for individuals in theearly stages of schizophrenia. The results will add to the knowledge about strategies to promote cognitive skills and functionalimpairment in daily life.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Changes in Brain Volume Resulting from Cognitive Intervention by Means of the Feuerstein Instrumental Enrichment Program in Older Adults with Mild Cognitive Impairment (MCI): A Pilot Study
    Dwolatzky, Tzvi
    Feuerstein, Refael S.
    Manor, David
    Cohen, Shlomit
    Devisheim, Haim
    Inspector, Michael
    Eran, Ayelet
    Tzuriel, David
    BRAIN SCIENCES, 2021, 11 (12)
  • [42] A qualitative study exploring the acceptability of a telehealth intervention for family members of people experiencing a first episode psychosis: PERCEPTION
    Marshall, David
    O'Keeffe, Donal
    Carroll, Megan
    Cleary, Emily
    Ryan, Dearbhail
    Counihan, Eimear
    Naughton, Sean
    Geary, Eoin
    Clarke, Mary
    IRISH JOURNAL OF PSYCHOLOGICAL MEDICINE, 2024,
  • [43] Development of the First Episode Digital Monitoring mHealth Intervention for People With Early Psychosis: Qualitative Interview Study With Clinicians
    Stefancic, Ana
    Rogers, R. Tyler
    Styke, Sarah
    Xu, Xiaoyan
    Buchsbaum, Richard
    Nossel, Ilana
    Cabassa, Leopoldo J.
    Stroup, T. Scott
    Kimhy, David
    JMIR MENTAL HEALTH, 2022, 9 (11):
  • [44] Implementing an early intervention program for first-episode psychosis in a Japanese clinical setting: a preliminary descriptive study
    Ono, Takashi
    Kayama, Akemi
    Saito, Kazuko
    Funakoshi, Syunichi
    Kakuto, Yoshihisa
    Abe, Koichi
    Otsuka, Tatsui
    Nomura, Ryo
    Hiroshi, Komatsu
    Matsumoto, Kazunori
    Kodaka, Akira
    Matsuoka, Hiroo
    EARLY INTERVENTION IN PSYCHIATRY, 2014, 8 : 156 - 156
  • [45] An open-label randomised comparison of aripiprazole, olanzapine and risperidone for the acute treatment of first-episode schizophrenia: Eight-week outcomes
    Cheng, Zhang
    Yuan, Yanbo
    Han, Xue
    Yang, Lei
    Cai, Shangli
    Yang, Fude
    Lu, Zheng
    Wang, Chuanyue
    Deng, Hong
    Zhao, Jingping
    Xiang, Yutao
    Correll, Christoph U.
    Yu, Xin
    JOURNAL OF PSYCHOPHARMACOLOGY, 2019, 33 (10) : 1227 - 1236
  • [46] PLAN-e-PSY, a mobile application to improve case management and patient's functioning in first episode psychosis: protocol for an open-label, multicentre, superiority, randomised controlled trial
    Haesebaert, Frederic
    El Oussoul, Sofia
    Pavard, Amelie
    Fabre, Delphine
    Cellard, Caroline
    Magaud, Laurent
    Subtil, Fabien
    Damiolini, Eleonore
    Fakra, Eric
    Haesebaert, Julie
    BMJ OPEN, 2021, 11 (09):
  • [47] Patients' and Family Members' Experiences of a Psychoeducational Family Intervention after a First Episode Psychosis: A Qualitative Study
    Nilsen, Liv
    Frich, Jan C.
    Friis, Svein
    Rossberg, Jan Ivar
    ISSUES IN MENTAL HEALTH NURSING, 2014, 35 (01) : 58 - 68
  • [48] Efficacy and Tolerability of Paliperidone Extended-release in the Treatment of First-episode Psychosis: An Eight-week, Open-label, Multicenter Trial
    Kang, Nam-In
    Koo, Bon-Noon
    Kim, Sung-Wan
    Kim, Jong-Noon
    Nam, Beomwoo
    Lee, Bong-Ju
    Lee, Sang-Hyuk
    Lee, Seung Jae
    Lee, Seung-Hwan
    Jung, Myung Hun
    Hahn, Sang Woo
    Chung, Young-Chul
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2016, 14 (03) : 261 - 269
  • [49] Efficacy of low-dose risperidone in combination with sertraline in first-episode drug-naive patients with schizophrenia: a randomized controlled open-label study
    Lang, Xiaoe
    Xue, Mei
    Zang, Xiaocui
    Wu, Fengchun
    Xiu, Meihong
    Zhang, Xiangyang
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [50] Aripiprazole for Drug-Naive or Antipsychotic-Short-Exposure Subjects With Ultra-High Risk State and First-Episode Psychosis An Open-Label Study
    Liu, Chen-Chung
    Chien, Yi-Ling
    Hsieh, Ming H.
    Hwang, Tzung-Jeng
    Hwu, Hai-Gwo
    Liu, Chih-Min
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2013, 33 (01) : 18 - 23